OKYO Pharma (NASDAQ:OKYO) Earns Buy Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of OKYO Pharma (NASDAQ:OKYO – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $4.00 price target on the stock. OKYO Pharma Stock Down 1.8 % OKYO Pharma stock opened at $1.67 on Tuesday. OKYO Pharma has a twelve […]

Leave a Reply

Your email address will not be published.

Previous post BMO Capital Markets Initiates Coverage on Hamilton Insurance Group (NYSE:HG)
Next post Fiserv (NYSE:FI) Earns Outperform Rating from Analysts at BMO Capital Markets